Mec Company (4971) · RiskRestated
The Burden of R&D Investment and Misjudging Market Needs
First written in FY2016. 3 of 4 entries say "Restated". Latest entry: FY2021.
4entries
7years
0from disclosures
How it moved
Same theme, other companies
Risk of R&D investments failing to deliver resultsA theme 116 companies write about · 116 as a headwind · 0 as a tailwind
The whole theme swung hardest in 2026: 14 of 29 companies on the "Worse" side.
74 other companies' latest entry also says "Restated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 116 companies compared. The sentences above are computed from all 116.Full recordFilings, disclosures and news, newest first
- FY2021RestatedAnnual report
「当社は、連結売上高の約10％を目安として研究開発投資を行っております。」
研究開発投資の負担と、市場ニーズの分析を誤ることによる販売減少のリスクを、連結売上高約10％という水準とともに再掲している。 - FY2018RestatedAnnual report
「Accordingly, we invest in R&D with a target of approximately 10% of consolidated net sales.」
研究開発投資を連結売上高の約10％とする水準と、収益化や市場ニーズの見誤りに関するリスクを再掲している。 - FY2017RestatedAnnual report
「Accordingly, we invest in R&D with a target of approximately 10% of consolidated net sales.」
研究開発投資を連結売上高の約10％とする水準と、投資が十分な収益につながらない場合や市場ニーズを誤る場合のリスクを再掲している。 - FY2016First statedAnnual report
「Accordingly, we invest in R&D with a target of approximately 10% of consolidated net sales.」
The company identifies the burden of R&D investment if commercialization is insufficient, as well as the risk of misjudging market needs and failing to respond to technological innovation.